+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


qPCR Reagents Market - Growth, Trends, and Forecasts (2020 - 2025)

  • ID: 4896266
  • Report
  • August 2020
  • Region: Global
  • 111 Pages
  • Mordor Intelligence


  • Affymetrix, Inc.
  • F. Hoffman-La Roche Ltd.
  • Promega Corporation
  • Quanta Biosciences, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific
A real-time polymerase chain reaction (real-time PCR) or quantitative polymerase chain reaction (qPCR), is a laboratory technique of molecular biology based on the polymerase chain reaction (PCR). It monitors the amplification of a targeted DNA molecule during the PCR.

Rising incidence of infectious diseases and genetic diseases have increased the demand for diagnostic tests that may help people take precautionary measures. Growing geriatric population has also increased the demand for fpr genetic tests. Many genome projects have been initiated in the past decade. This has allowed researchers to understand the human genome more. These projects require gene sequencing and genetic tests to understand the human gene sequence. These demand s have helped the growth of qPCR equipment, which has in turn boosted the growth of qPCR equipment market.

However, the high cost of qPCR equipment and lack of high technical expertise to operate qPCR equipment have been restraining the market growth.

Key Market Trends

Dye-Based qPCR Reagents are Expected to Dominate the Market

The use of fluorescent DNA-binding dyes is one of the most straightforward and common qPCR approaches used by scientists. A dye is added to the reaction, and fluorescence is measured at each PCR cycle. Because fluorescence of these dyes increases dramatically in the presence of double-stranded DNA, DNA synthesis can be monitored as an increase in fluorescent signal.

Dye-based diagnostic qualitative PCR is applied to rapidly detect nucleic acids that are diagnostic of, for example, infectious diseases, cancer and genetic abnormalities. Moreover, Cancer Research UK suggests that the population suffering from cancer is expected to increase in the future. As per the report, if recent trends in incidence of major cancers and population growth are consistent, it is predicted there will be 27.5 million new cancer cases worldwide each year by 2040. This is an increase of 61.7% from 2018 (17 million).

North America is Expected to Dominate the Market

Prevalence of cancer in United States is one of the highest in North American countries. According to a 2018 report by the National Cancer Institute, the incidence of cancer in the US is 439.2 per 100,000 men and women per year. Prevalence of infectious disease is also high in United States and Mexico. This has created high demand for qPCR diagnostic tests, which is increasing the demand for qPCR reagents as well.

However, the United States has a developed and well-structured health care system. The system also encourages research and development. These policies encourage global players to enter the US, and eventually the North American market. As a result, this region enjoys the presence of many global market players. As high demand is met by the presence of global players in the region, the market is further expected to increase.

Competitive Landscape

Majority of the qPCR reagents are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market grow.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Note: Product cover images may vary from those shown


  • Affymetrix, Inc.
  • F. Hoffman-La Roche Ltd.
  • Promega Corporation
  • Quanta Biosciences, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Incidence of Infectious Diseases and Genetic Disorders
4.2.2 Growing Geriatric Population
4.2.3 Increasing Focus on Human Genome Projects
4.3 Market Restraints
4.3.1 High Cost of Reagents and qPCR Equipment
4.3.2 Lack of Technical Expertise to Operate the qPCR instrument
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Detection Method
5.1.1 Dye-Based qPCR Reagents
5.1.2 Probes and Primer-Based qPCR Reagents
5.2 By Packaging Type
5.2.1 qPCR Core Kits
5.2.2 qPCR Mastermixes
5.3 By End-User
5.3.1 Hospitals & Diagnostic Centers
5.3.2 Research Laboratories & Academic Institutes
5.3.3 Others
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.4.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Affymetrix, Inc.
6.1.2 Agilent Technologies, Inc.
6.1.3 Bio-Rad Laboratories, Inc.
6.1.4 F. Hoffman-La Roche Ltd.
6.1.5 Promega Corporation
6.1.6 Quanta Biosciences, Inc.
6.1.7 Sigma-Aldrich Corporation (Merck KGaA)
6.1.8 Takara Bio Inc.
6.1.9 Thermo Fisher Scientific
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffman-La Roche Ltd.
  • Promega Corporation
  • Quanta Biosciences, Inc.
  • Sigma-Aldrich Corporation (Merck KGaA)
  • Takara Bio Inc.
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown